Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Supramolecular Site-Specific Antibody Drug Conjugates Outperform Cysteine-Conjugated Analogs in Pancreatic Peritoneal Carcinomatosis.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026
Anti-DEspR antibody treatment improves survival and reduces neurologic deficits in a hypertensive, spontaneous intracerebral hemorrhage (hsICH) rat model.
Journal: Scientific reports
Published: April 03, 2022
Increased Neutrophil-Subset Associated With Severity/Mortality In ARDS And COVID19-ARDS Expresses The Dual Endothelin-1/VEGFsignal-Peptide Receptor (DEspR): An Actionable Therapeutic Target.
Journal: Research square
Published: September 21, 2021
A targetable 'rogue' neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS.
Journal: Scientific reports
Published: August 25, 2021
Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model.
Journal: BMC cancer
Published: December 28, 2020
Autoimmune Gastrointestinal Dysmotility in a Patient With HIV Treated With Methylprednisolone and Pyridostigmine.
Journal: ACG case reports journal
Published: September 28, 2020
Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease.
Journal: Cancer research
Published: September 07, 2019
MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer.
Journal: Cancer biology & therapy
Published: March 30, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026